Silence Therapeutics Plc
(NASDAQ) SLN
Silence Therapeutics Plc Financials at a Glance
Market Cap
$472.35M
Revenue (TTM)
$921.49K
Net Income (TTM)
-$85.17M
EPS (TTM)
-$1.59
P/E Ratio
-6.28
Dividend
$0.00
Beta (Volatility)
0.70 (Low)
Dividend
$0.00
Beta (Volatility)
0.70 (Low)
Price
$10.07
Volume
1,080,895.123
Open
$9.91
Price
$10.07
Volume
1,080,895.123
Open
$9.91
Previous Close
$10.14
Daily Range
$9.89 - $10.63
52-Week Range
$4.19 - $10.63
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
0.70 (Low)
Price
$10.07
Volume
1,080,895.123
Open
$9.91
Previous Close
$10.14
Daily Range
$9.89 - $10.63
52-Week Range
$4.19 - $10.63
Estimated Earnings Date
Aug 6, 2026
SLN News
SLN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Silence Therapeutics Plc
Industry
Biotechnology
Sector
Health CareEmployees
88
CEO
Iain Gladstone Ross
Website
www.silence-therapeutics.comHeadquarters
London, W14 8TH, GB
SLN Financials
Key Financial Metrics (TTM)
Gross Margin
66.43%
Operating Margin
-9396.64%
Net Income Margin
-9243.05%
Return on Equity
-121.71%
Return on Capital
-143.69%
Return on Assets
-73.99%
Earnings Yield
-15.92%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$472.35M
Shares Outstanding
47.23M
Volume
1.08M
Avg. Volume
352.56K
Financials (TTM)
Gross Profit
$612.12K
Operating Income
-$86.59M
EBITDA
-$78.13M
Operating Cash Flow
-$65.57M
Capital Expenditure
-$106.00K
Free Cash Flow
-$65.67M
Cash & ST Invst.
$70.08M
Total Debt
$136.00K
Silence Therapeutics Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$421.29K
+129.3%
Gross Profit
$304.49K
+167.5%
Gross Margin
72.27%
N/A
Market Cap
$472.35M
N/A
Market Cap/Employee
$4.07M
N/A
Employees
116
N/A
Net Income
-$14.93M
+59.5%
EBITDA
-$14.83M
+59.6%
Quarterly Fundamentals
Total Cash
$70.08M
-48.7%
Total Debt
$136.00K
+126.7%
Accounts Receivable
$22.22M
+31.9%
Inventory
$0.00
N/A
Long Term Debt
$43.00K
N/A
Short Term Debt
$93.00K
+55.0%
Return on Assets
-73.99%
N/A
Return on Invested Capital
-82.73%
N/A
Free Cash Flow
-$15.60M
-26.7%
Operating Cash Flow
-$15.60M
-26.8%